APA (7th ed.) Citation

C, E., P, C., JM, F. R., I, G., A, L., AI, P., . . . A, E. (2025). Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: A narrative review of real-world evidence studies. Frontiers in cardiovascular medicine, 12, 1644646. https://doi.org/10.3389/fcvm.2025.1644646

Chicago Style (17th ed.) Citation

C, Escobar, Caravaca-Pérez P, Fernandez Rodriguez JM, Gomez-Otero I, Lozano-Bahamonde A, Pérez-Cabeza AI, Pérez-Silvestre J, Rafols C, and Esteban-Fernández A. "Effectiveness and Safety of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction: A Narrative Review of Real-world Evidence Studies." Frontiers in Cardiovascular Medicine 12 (2025): 1644646. https://doi.org/10.3389/fcvm.2025.1644646.

MLA (9th ed.) Citation

C, Escobar, et al. "Effectiveness and Safety of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction: A Narrative Review of Real-world Evidence Studies." Frontiers in Cardiovascular Medicine, vol. 12, 2025, p. 1644646, https://doi.org/10.3389/fcvm.2025.1644646.